- CG Oncology, which develops treatments for bladder cancer, is receiving analyst attention regarding its potential benefits from Trump-era tariffs and the broader upside in AI stocks.
- CG Oncology, Inc. is developing targeted oncolytic virus therapy for high-risk non-muscle invasive bladder cancer.
A unanimous jury verdict was issued in the Delaware Superior Court on July 30, 2025, rejecting Ani's claims for unjust enrichment damages in a lawsuit involving CG Oncology, Inc.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A unanimous jury verdict was issued in the Delaware Superior Court on July 30, 2025, rejecting Ani's claims for unjust enrichment damages in a lawsuit involving CG Oncology, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ani
singer songwriter
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireDelaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology,